The Preclinical CRO Market Is Predicted To Reach USD 4.84 Billion With A CAGR Of 8.3% According To Market Data Forecast Report.

The Preclinical CRO Market Is Predicted To Reach USD 4.84 Billion With A CAGR Of 8.3% According To Market Data Forecast Report.

ID: 6700 | October 2018 | Region: Global


The Preclinical CRO Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Preclinical CRO Market is estimated to be USD 3.25 billion in 2017 and predicted to rise to USD 3.25 billion by 2022 with a CAGR of 8.3%. The market is segmented by service type (bioanalysis and DMPK studies, toxicology testing and other preclinical services) , by end user ( biopharmaceutical companies, government and academic institutes and medical device companies) . Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Increasing number of life science of companies and outsourcing of various functions is driving the market growth. The rising number of R&D projects in the clinical phase segment are further propelling the market growth. Due to the failure of toxicology tests, the market is growing significantly. Supportive government policies regarding drug approval is expected to fuel the market growth during the forecast period.

The market for Preclinical CRO Agents is broadly categorized into service type and end user. By service type the market is segmented into bioanalysis and DMPK studies, toxicology testing and other preclinical services. Toxicology testing holds the largest market share in the preclinical CRO market. By end user the market is divided into biopharmaceutical companies, government and academic institutes and medical device companies.  Biopharmaceutical companies are the biggest end user segment for preclinical CRO. On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Preclinical CRO Agents market was dominated by North America closely followed Europe. Asia Pacific is expected to grow at a high CAGR.

Some of the major companies dominating the market, by their products and services include Charles River Laboratories International, Inc.; Laboratory Corporation of America; Envigo, Eurofins Scientific; PRA Health Science, Inc.; Wuxi AppTec; Medpace, Inc.; Pharmaceutical Product Development, LLC.; and Paraxel International Corporation.

Browse through the full report at https://www.marketdataforecast.com/market-reports/preclinical-cRO-agents-market-6688/ and checkout our recent reports in the Pharmaceuticals at https://www.marketdataforecast.com/subcategory/pharmaceuticals-1/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.